We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+14.57%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$6.85B
AUM Growth
-$481M
Cap. Flow
-$845M
Cap. Flow %
-12.34%
Top 10 Hldgs %
41.03%
Holding
120
New
33
Increased
27
Reduced
18
Closed
27

Top Buys

Rank Stock Value
1
PCYC
PHARMACYCLICS INC
PCYC
+$376M
2
AGN
Allergan plc
AGN
+$262M
3
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$213M
4
HSP
HOSPIRA INC
HSP
+$179M
5
SIAL
SIGMA - ALDRICH CORP
SIAL
+$160M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$531M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$460M
3
SWY
SAFEWAY INC
SWY
+$318M
4
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$258M
5
ROC
ROCKWOOD HLDGS INC
ROC
+$184M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.56%
2 Healthcare 9.88%
3 Technology 9.5%
4 Communication Services 8.84%
5 Industrials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENTR
76
DELISTED
ENTROPIC COMMUNICATIONS INC COM STK (DE)
ENTR
$5.93M 0.09%
+2,002,000
New +$5.61M
LRMR icon
77
Larimar Therapeutics
LRMR
$436M
$5.15M 0.08%
10,833
+5,833
+117% +$2.77M
SFUN
78
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$3.63M 0.05%
+12,100
New +$4.03M
EJ
79
DELISTED
E HOUSE (CHINA) HOLDINGS LIMITED
EJ
$3.35M 0.05%
+617,500
New +$4.22M
MDRX
80
DELISTED
Veradigm Inc. Common Stock
MDRX
$2.99M 0.04%
+250,000
New +$3.05M
ADVM
81
DELISTED
Adverum Biotechnologies
ADVM
$2.63M 0.04%
+6,500
New +$2.75M
ISSI
82
DELISTED
INTEGRATED SILICON SOLUTN INC
ISSI
$1.97M 0.03%
+110,000
New +$1.85M
ARUN
83
CALL
DELISTED
ARUBA NETWORKS, INC.
ARUN
$1.88M 0.03%
+76,700
New +$1.54M
RPRX
84
DELISTED
Repros Therapeutics Inc.
RPRX
$1.72M 0.03%
200,000
-100,000
-33% -$894K
ZSPH
85
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$1.05M 0.02%
+25,000
New +$1.14M
EVFM
86
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$1.03M 0.02%
1,389
– –
EIGR
87
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$758K 0.01%
89
-355
-80% -$3.1M
AOI
88
DELISTED
Alliance One International
AOI
$639K 0.01%
+58,104
New +$652K
HELI
89
DELISTED
CHC GROUP LTD SHS NEW (CYM)
HELI
$333K ﹤0.01%
8,333
– –
AMAT icon
90
CALL
Applied Materials
AMAT
$419B
– –
-1,685,000
Closed -$42M
ASH icon
91
Ashland
ASH
$3.32B
– –
-468,076
Closed -$27.4M
BHC icon
92
CALL
Bausch Health
BHC
$2.21B
– –
-650,000
Closed -$93M
BHC icon
93
Bausch Health
BHC
$2.21B
– –
-46,000
Closed -$6.58M
CTSH icon
94
Cognizant
CTSH
$25.6B
– –
-850,000
Closed -$44.8M
GIB icon
95
CGI
GIB
$15.4B
– –
-831,300
Closed -$31.7M
OI icon
96
O-I Glass
OI
$1.09B
– –
-4,145,000
Closed -$112M
TSLA icon
97
PUT
Tesla
TSLA
$1.26T
– –
-7,500,000
Closed -$111M
AGN
98
CALL
DELISTED
Allergan plc
AGN
– –
-216,000
Closed -$55.6M
AGN
99
PUT
DELISTED
Allergan plc
AGN
– –
-216,000
Closed -$55.6M
COVS
100
DELISTED
Covisint Corporation
COVS
– –
-307,818
Closed -$816K
1 2 3
4
5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Farallon Capital Management held 120 positions worth $6.85B, down 6.6% from $7.33B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Farallon Capital Management withdrew a net $845M in Q1 2015, closing 27 positions and reducing 18 holdings. Its most notable exit was Allergan Inc, an estimated $531M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Farallon Capital Management opened a new position in PHARMACYCLICS INC worth $498M.

  • Farallon Capital Management's largest Q1 2015 buy was PHARMACYCLICS INC: 1,945,000 shares worth $498M.
  • Farallon Capital Management added most to Allergan plc in Q1 2015, an estimated $262M increase.
  • Farallon Capital Management's biggest Q1 2015 reduction was Coca-Cola Europacific Partners, cutting an estimated $123M.
  • Farallon Capital Management fully exited Allergan Inc in Q1 2015, selling an estimated $531M.
  • Farallon Capital Management's ten largest holdings make up 41% of its $6.85B portfolio in Q1 2015.
  • Farallon Capital Management opened 33 new positions and closed 27 in Q1 2015.
  • Farallon Capital Management's portfolio value fell 6.6% quarter-over-quarter to $6.85B.

Based on Farallon Capital Management's 13F filing for Q1 2015, filed 15 May 2015.